text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

请选择数量

A Novel Dipeptide-Based Chiral Phosphine Organocatalyst for Asymmetric Cyclization

The dipeptide-based chiral phosphine (1), which was developed by Lu et al., is an efficient and versatile organocatalyst for the [3+2] and [4+2] asymmetric cyclizations of allenoates with unsaturated compounds.1-3) For example, the [3+2] cyclization of allenoates with alkyl or arylimines proceeds in the presence of 5 mol% of 1, affording the reaction products in good yields and high enantioselectivities.1) Notably, 1 is stable in the air at room temperature.
Typical procedure (entry 1: R = CH3CH2CH2-): To a dried round bottom flask is added N-butylidene-P,P-diphenylphosphinic amide (27.1 mg, 0.1 mmol), O-TBDPS-D-Thr-N-Boc-L-tert-Leu-diphenylphosphine (3.6 mg, 0.005 mmol) and MS5Å (60 mg) under N2, followed by the addition of anhydrous Et2O (1 mL). The reaction mixture is cooled to 0 ºC, tert-butyl 2,3-butadienoate (22 micro-L, 0.15 mmol) is then added, and the mixture is stirred at 0 ºC for 30 min. The reaction mixture is then filtered (to remove MS5Å) and concentrated under reduced pressure. The residue is purified by column chromatography on silica gel (eluent: hexane/EtOAc = 10:1 to 2:1) to afford the cycloaddition product (37.9 mg, 92% yield, 96% ee) as a colorless oil.

References

The prices are subject to change without notice. Please confirm the newest price by our online catalog before placing an order.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.
會話狀態
當前會話將在10分鐘後超時,並返回主頁。請點擊按鈕繼續瀏覽。分鐘後超時,並返回主頁。請點擊按鈕繼續瀏覽。

您的會話已超時,將返回至主頁。